Predictmedix Inc (CSE:PMED) (OTCQB:PMEDF) revealed Tuesday that it has entered into a letter of intent (LOI) to acquire Symp2Pass Inc, an AI-powered IoT product suite of technologies, in a $5 million cash and stock deal. Symp2Pass, developed by SmartCone Technologies Inc, is one of the first end-to-end advanced touchless health and wellness testing solutions that provides coronavirus (COVID-19) symptom screening from multiple independent sensors with geolocation mapping, the company noted. Symp2Pass’s thermal scanning capabilities allow scans to be completed with an accuracy of ± 0.54° Farenheit and can scan up to 30 people at a distance of more than nine feet, it added. With Predictmedix’s infectious disease screening algorithms, the company said it will be able to develop non-invasive screening at scale.
VolitionRx Limited (NYSEAMERICAN:VNRX) CEO Cameron Reynolds told shareholders on Tuesday that the epigenetics company is in its “strongest-ever financial position” to support and develop its diagnostic tests. The company shared full-year 2020 financial results, which showed it had cash and cash equivalents of $19.4 million on December 31, 2020, compared with $17 million at the end of December 2019. More importantly, after a public offering in February, VolitionRx’s cash and equivalents shot up to $40 million before deducting expenses incurred so far in 2021. During the first quarter of 2021, the firm added nearly $20.5 million in cash mostly through the underwritten public offering.
CleanSpark Inc (NASDAQ:CLSK) said it has executed more than 50 new contracts under its residential initiative in less than one month following its acquisition of Solar Watt Solutions. The company noted the additional contracts for residential microgrids and battery energy storage solutions executed since February 24 have a face value exceeding $1.7 million. “Acquiring an existing partner was a deliberate move to further our reach into the residential markets as our cross-functional teams already had experience working together. This experience enabled us to decrease